Logo image of BALY

BALLY'S CORP (BALY) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:BALY - US05875B3042 - Common Stock

17.76 USD
+0.47 (+2.72%)
Last: 12/26/2025, 8:04:00 PM
17.76 USD
0 (0%)
After Hours: 12/26/2025, 8:04:00 PM
Fundamental Rating

2

BALY gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 133 industry peers in the Hotels, Restaurants & Leisure industry. BALY has a bad profitability rating. Also its financial health evaluation is rather negative. BALY is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BALY had negative earnings in the past year.
In the past year BALY has reported a negative cash flow from operations.
In the past 5 years BALY always reported negative net income.
BALY had a positive operating cash flow in each of the past 5 years.
BALY Yearly Net Income VS EBIT VS OCF VS FCFBALY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M -400M

1.2 Ratios

Looking at the Return On Assets, with a value of -5.74%, BALY is doing worse than 75.19% of the companies in the same industry.
BALY's Return On Equity of -83.15% is on the low side compared to the rest of the industry. BALY is outperformed by 66.17% of its industry peers.
The Return On Invested Capital of BALY (0.97%) is worse than 75.19% of its industry peers.
Industry RankSector Rank
ROA -5.74%
ROE -83.15%
ROIC 0.97%
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
BALY Yearly ROA, ROE, ROICBALY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

BALY's Operating Margin of 3.25% is on the low side compared to the rest of the industry. BALY is outperformed by 69.92% of its industry peers.
The Gross Margin of BALY (55.16%) is better than 66.92% of its industry peers.
In the last couple of years the Gross Margin of BALY has declined.
Industry RankSector Rank
OM 3.25%
PM (TTM) N/A
GM 55.16%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
BALY Yearly Profit, Operating, Gross MarginsBALY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

0

2. Health

2.1 Basic Checks

BALY has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, BALY has more shares outstanding
BALY has more shares outstanding than it did 5 years ago.
BALY has a worse debt/assets ratio than last year.
BALY Yearly Shares OutstandingBALY Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
BALY Yearly Total Debt VS Total AssetsBALY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

BALY has an Altman-Z score of 0.34. This is a bad value and indicates that BALY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.34, BALY is doing worse than 79.70% of the companies in the same industry.
A Debt/Equity ratio of 7.14 is on the high side and indicates that BALY has dependencies on debt financing.
BALY has a Debt to Equity ratio of 7.14. This is in the lower half of the industry: BALY underperforms 63.91% of its industry peers.
Industry RankSector Rank
Debt/Equity 7.14
Debt/FCF N/A
Altman-Z 0.34
ROIC/WACC0.11
WACC8.84%
BALY Yearly LT Debt VS Equity VS FCFBALY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

BALY has a Current Ratio of 0.68. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
BALY's Current ratio of 0.68 is on the low side compared to the rest of the industry. BALY is outperformed by 65.41% of its industry peers.
BALY has a Quick Ratio of 0.68. This is a bad value and indicates that BALY is not financially healthy enough and could expect problems in meeting its short term obligations.
BALY has a worse Quick ratio (0.66) than 63.91% of its industry peers.
Industry RankSector Rank
Current Ratio 0.68
Quick Ratio 0.66
BALY Yearly Current Assets VS Current LiabilitesBALY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

BALY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 37.09%, which is quite impressive.
The Revenue has been growing slightly by 0.36% in the past year.
BALY shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 36.16% yearly.
EPS 1Y (TTM)37.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
Revenue 1Y (TTM)0.36%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.36%

3.2 Future

The Earnings Per Share is expected to grow by 22.49% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 6.41% on average over the next years.
EPS Next Y47.43%
EPS Next 2Y33.88%
EPS Next 3Y22.49%
EPS Next 5YN/A
Revenue Next Year3.35%
Revenue Next 2Y3.93%
Revenue Next 3Y6.41%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BALY Yearly Revenue VS EstimatesBALY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BALY Yearly EPS VS EstimatesBALY Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -2 -4 -6 -8 -10

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BALY. In the last year negative earnings were reported.
Also next year BALY is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BALY Price Earnings VS Forward Price EarningsBALY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80 100

4.2 Price Multiples

BALY's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.23
BALY Per share dataBALY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 -40 -60

4.3 Compensation for Growth

A more expensive valuation may be justified as BALY's earnings are expected to grow with 22.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.88%
EPS Next 3Y22.49%

0

5. Dividend

5.1 Amount

BALY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

BALLY'S CORP

NYSE:BALY (12/26/2025, 8:04:00 PM)

After market: 17.76 0 (0%)

17.76

+0.47 (+2.72%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)11-12 2025-11-12/bmo
Earnings (Next)03-03 2026-03-03/amc
Inst Owners77.54%
Inst Owner Change-3.9%
Ins Owners12.56%
Ins Owner Change0.14%
Market Cap873.08M
Revenue(TTM)2.49B
Net Income(TTM)-433.64M
Analysts50
Price Target17.39 (-2.08%)
Short Float %1.05%
Short Ratio2.88
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-828.99%
Min EPS beat(2)-1443.99%
Max EPS beat(2)-213.99%
EPS beat(4)1
Avg EPS beat(4)-456.79%
Min EPS beat(4)-1443.99%
Max EPS beat(4)18.41%
EPS beat(8)2
Avg EPS beat(8)-657.28%
EPS beat(12)2
Avg EPS beat(12)-872.87%
EPS beat(16)4
Avg EPS beat(16)-658.21%
Revenue beat(2)0
Avg Revenue beat(2)-1.1%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.29%
Revenue beat(4)0
Avg Revenue beat(4)-2.47%
Min Revenue beat(4)-4.31%
Max Revenue beat(4)-0.29%
Revenue beat(8)0
Avg Revenue beat(8)-3.44%
Revenue beat(12)0
Avg Revenue beat(12)-2.96%
Revenue beat(16)0
Avg Revenue beat(16)-3.78%
PT rev (1m)1.19%
PT rev (3m)36.95%
EPS NQ rev (1m)0.26%
EPS NQ rev (3m)-8.26%
EPS NY rev (1m)-46.3%
EPS NY rev (3m)-46.3%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.39%
Revenue NY rev (1m)-0.38%
Revenue NY rev (3m)-0.38%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 1.67
P/tB N/A
EV/EBITDA 12.23
EPS(TTM)-7.7
EYN/A
EPS(NY)-2.43
Fwd EYN/A
FCF(TTM)-6.18
FCFYN/A
OCF(TTM)-1.47
OCFYN/A
SpS50.67
BVpS10.61
TBVpS-62.12
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -5.74%
ROE -83.15%
ROCE 1.22%
ROIC 0.97%
ROICexc 0.99%
ROICexgc 2.22%
OM 3.25%
PM (TTM) N/A
GM 55.16%
FCFM N/A
ROA(3y)-6.39%
ROA(5y)-4.24%
ROE(3y)-639.86%
ROE(5y)-385.68%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.11%
GM growth 5Y-3.47%
F-Score6
Asset Turnover0.33
Health
Industry RankSector Rank
Debt/Equity 7.14
Debt/FCF N/A
Debt/EBITDA 10.22
Cap/Depr 81.78%
Cap/Sales 9.3%
Interest Coverage 0.24
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.68
Quick Ratio 0.66
Altman-Z 0.34
F-Score6
WACC8.84%
ROIC/WACC0.11
Cap/Depr(3y)125.58%
Cap/Depr(5y)105.92%
Cap/Sales(3y)17.68%
Cap/Sales(5y)13.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)37.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%66.67%
EPS Next Y47.43%
EPS Next 2Y33.88%
EPS Next 3Y22.49%
EPS Next 5YN/A
Revenue 1Y (TTM)0.36%
Revenue growth 3Y22.83%
Revenue growth 5Y36.16%
Sales Q2Q%5.36%
Revenue Next Year3.35%
Revenue Next 2Y3.93%
Revenue Next 3Y6.41%
Revenue Next 5YN/A
EBIT growth 1Y279.76%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year346.53%
EBIT Next 3Y63.6%
EBIT Next 5YN/A
FCF growth 1Y21.54%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-144.44%
OCF growth 3Y11.25%
OCF growth 5Y3.91%

BALLY'S CORP / BALY FAQ

What is the ChartMill fundamental rating of BALLY'S CORP (BALY) stock?

ChartMill assigns a fundamental rating of 2 / 10 to BALY.


What is the valuation status of BALLY'S CORP (BALY) stock?

ChartMill assigns a valuation rating of 1 / 10 to BALLY'S CORP (BALY). This can be considered as Overvalued.


How profitable is BALLY'S CORP (BALY) stock?

BALLY'S CORP (BALY) has a profitability rating of 1 / 10.


Can you provide the expected EPS growth for BALY stock?

The Earnings per Share (EPS) of BALLY'S CORP (BALY) is expected to grow by 47.43% in the next year.


Can you provide the dividend sustainability for BALY stock?

The dividend rating of BALLY'S CORP (BALY) is 0 / 10 and the dividend payout ratio is 0%.